nonprofit logo

The Mark Foundation For Cancer Research (Us) Ltd

Learn about this cause: Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 364825921 ✦ New york, NY ✦ Designated as a 501(c)(3)

Overview

What is The Mark Foundation For Cancer Research (Us) Ltd?

The Mark Foundation for Cancer Research (Us) Ltd is a New York-based nonprofit organization dedicated to fueling innovation and advancements in cancer research. Through rigorous grant programs, the foundation supports both individual investigators and multidisciplinary collaborative teams, fostering a network of leading scientific minds in the field. Their mission focuses on advancing breakthrough research and accelerating the prevention, diagnosis, and treatment of cancer through nimble, high-impact funding approaches. The foundation's grants are subjected to stringent peer review and uphold the highest standards of scientific excellence. In summary, the Mark Foundation for Cancer Research is an active partner in cancer research, driving transformative research through grants and venture investments.


Official website here: www.themarkfoundation.org

Is The Mark Foundation For Cancer Research (Us) Ltd legitimate?

The Mark Foundation For Cancer Research (Us) Ltd is a legitimate nonprofit organization registered as a 501(c)(3) entity. The Mark Foundation For Cancer Research (Us) Ltd submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.

Here are some key statistics you may want to consider:

Executive Compensation: $1,716,657
Professional Fundraising Fees: $0
Other Salaries and Wages: $937,685

For more financial information, click here


Official website here: www.themarkfoundation.org

What is the mission statement of The Mark Foundation For Cancer Research (Us) Ltd?

The Mark Foundation for Cancer Research (Us) Ltd is dedicated to advancing cancer research, detection, prevention, and cures through a nimble and high-impact funding approach. They collaborate with scientists to accelerate research that transforms the prevention, diagnosis, and treatment of cancer. The foundation supports both individual investigators and multidisciplinary collaborative teams, rewarding innovative thinking that advances the understanding of cancer biology and improves oncology treatment paradigms. Grantees join the foundation's network of leading scientific minds in cancer research and technological innovation. Submissions undergo rigorous peer review by the foundation's Scientific Advisory Committee or subject matter experts, adhering to the highest standards of scientific excellence.


Official website here: www.themarkfoundation.org

Who is the CEO of The Mark Foundation For Cancer Research (Us) Ltd?

Ryan Schoenfeld is the Director of The Mark Foundation For Cancer Research (Us) Ltd. The CEO's salary of The Mark Foundation For Cancer Research (Us) Ltd is $464,180 and their total compensation is $528,281.


Official website here: www.themarkfoundation.org

What is the revenue of The Mark Foundation For Cancer Research (Us) Ltd?

The Mark Foundation For Cancer Research (Us) Ltd's revenue in 2022 was $55,345,494.


Official website here: www.themarkfoundation.org

Who are the executives of The Mark Foundation For Cancer Research (Us) Ltd and what are their salaries?

The average compensation at The Mark Foundation For Cancer Research (Us) Ltd during 2022 was $294,927. There are 9 employees at The Mark Foundation For Cancer Research (Us) Ltd.

Here are 14 key members and their salaries (The Mark Foundation For Cancer Research (Us) Ltd's CEO's salary is $464,180 and their total compensation is $528,281):

    Ryan Schoenfeld (Chief Executive Officer)
  • Compensation: $464,180
  • Related: $0
  • Other: $64,101

    • Raymond Dubois (Executive Chairman Of The Board) [Trustee/Director]
  • Compensation: $513,333
  • Related: $0
  • Other: $0

    • S Patrick Lewis (Head Of Finance And Operations)
  • Compensation: $283,875
  • Related: $0
  • Other: $111,866

    • Anna Turetsky (Principal, Venture Investments)
  • Compensation: $279,950
  • Related: $0
  • Other: $53,426

    • Rebecca Bish-Cornelissen (Head Of Pre-Clinical Research)
  • Compensation: $293,452
  • Related: $0
  • Other: $34,907

    • Rebecca Liu (Director Of Grants Administration)
  • Compensation: $178,022
  • Related: $0
  • Other: $38,545

    • Janice Lin (Portfolio Mgr, Research/Investments)
  • Compensation: $136,072
  • Related: $0
  • Other: $21,790

    • Robert Magin (Associate Scientific Director)
  • Compensation: $127,472
  • Related: $0
  • Other: $23,181

    • Irena Ivanovska (Senior Scientific Research)
  • Compensation: $106,711
  • Related: $0
  • Other: $19,504

    • Ross Levine (Director)
  • Compensation: $10,000
  • Related: $0
  • Other: $0

    • Stuart Thomson (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • William Allen Shapard (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Kevin O' Flaherty (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Paul Pospisil (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0


  • Official website here: www.themarkfoundation.org

    Where can I find the form 990 for The Mark Foundation For Cancer Research (Us) Ltd?

    The The Mark Foundation For Cancer Research (Us) Ltd’s most recent form 990 was submitted in 2022 and can be accessed here


    Official website here: www.themarkfoundation.org

    Learn more at the official website: www.themarkfoundation.org

    Mission Statement of The Mark Foundation For Cancer Research (Us) Ltd

    The Mark Foundation For Cancer Research (Us) Ltd is a dynamic organization dedicated to advancing breakthroughs in cancer research, detection, prevention, and cures. This foundation actively collaborates with scientists to accelerate research that transforms the way we prevent, diagnose, and treat cancer. Through a nimble, high-impact funding approach, the organization supports both basic and translational cancer research via grants and venture investments.

    The foundation's grants reward innovative thinking and push the boundaries of cancer biology, aiming to improve oncology treatment paradigms. The grantees become a part of a distinguished network of the best scientific minds in cancer research and technological innovation. Every grant submission undergoes rigorous peer review by the foundation's Scientific Advisory Committee or subject matter experts, ensuring the highest standards of scientific excellence are met.

    In essence, The Mark Foundation For Cancer Research (Us) Ltd is a driving force in the cancer research community, championing groundbreaking discoveries that have the potential to revolutionize the way we approach cancer prevention, diagnosis, and treatment. By fostering collaborations between scientists, the foundation plays a crucial role in propelling the field forward and ultimately contributing to a future where cancer is no longer a death sentence.

    Impact

    This information is meant to be a general summary of The Mark Foundation For Cancer Research (Us) Ltd. Please take the time to review official sources before making any decisions based upon the content provided here.




    Thursday, August 15, 2024

    The Mark Foundation For Cancer Research (Us) Ltd's impact lies in advancing basic breakthrough cancer research, detection, prevention, and cures for cancer. The foundation provides grants that reward innovative thinking, advance the understanding of cancer biology, and improve oncology treatment paradigms. By supporting individual investigators and multidisciplinary collaborative teams across various cancer types, the foundation creates a network of the best scientific minds in cancer research and technological innovation. Grant submissions undergo rigorous peer review to ensure the highest standards of scientific excellence. The foundation actively partners with scientists to accelerate research that transforms the prevention, diagnosis, and treatment of cancer through a nimble, high-impact funding approach in basic and translational cancer research.





    Financials

    This financial information is from Propublica.

    Revenue
    Expenses
    Efficiency

    Other financial information:

    This information is from the most recently submitted tax form from this organization, which was in 2022.

  • Investment Income: $363,707
  • Program Service Revenue: $0
  • Gross Receipts: $55,345,494

    • Assets and Liabilities:
  • Total Assets: $110,652,350
  • Total Liabilities: $28,107,967
  • Net Assets: $82,544,383
  • Organization Details

    Founding Year

    2015

    Principal Officer

    Ryan Schoenfeld

    Main Address

    1350 AVENUE OF THE AMERICAS 2902, NEW YORK, NY, 10019

    NTEE Category

    Code: H30 - Medical research

    If you are a representative of The Mark Foundation For Cancer Research (Us) Ltd and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.